Investment to help Dow Microbial Control commercialise its products
26/09/2012
As a result, it will have $50 million in investment between now and 2014 from parent company Dow Chemical, which it will use to continue developing and commercialising its technologies in an effort to help make “environmentally preferred” solutions available to user organisations.
Greg Bradley, the company’s associate director of regulatory sciences and product sustainability, said ongoing commitment and investment in regulatory expertise helped put Dow Microbial in a position to be able to navigate a complex regulatory environment for customers.